Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$LABD $14.10 Buying some here looking for a biotech bounce downward in the short term...
Current Positions as of 01/05/17:
$LABU 3/4 position @ $34.16
$LXRX 3/4 position @ $14.61
$SGYP 1/2 position @ $5.97
$XBI FULL position @ $63.15
$XXII 1/2 position @ $0.92
I plan to update the iBox over the next few days to document closed trades and will post thoughts on 2016 performance, lessons learned and plan going forward in 2017
$LABU $37.35 Sold tranche here at the open and re-bought as it dipped to $35.95. This has been a really good trader for a patient investor that likes to buy in tranches... which matches my style nicely
$XXII $0.87 Buying more here on the pullback. This continues to be a good trader in the past. This looks like an excellent entry
FDA reply on their application to market their VLN. "very low nicotine" cigarettes as "modified risk". This would be the first and only company able to market cigarettes as modified risk. Would be huge and lead to significant partnerships with big boys
Get out the VOTE!
While I'm just getting started with this sort of thing, I would appreciate a vote for me if you think I have been a helpful or inspiring trader on Twitter & this board!
Type in @kklar1
If you want to show your appreciation, then VOTE! I am in the fill in section.
Thank you!
This is my first full year on my own board and my goal from the start is to help inspire others as a trader/person.
http://www.newtraderu.com/2016/12/26/5th-annual-helpful-trader-twitter-poll-2016/
$LXRX $16.30 Sold my first tranche here on today's pop. The action has been a bit better in the recent days and I managed to lock in 3% gains - still holding 3/4 position and hopefully it will continue to improve as it approaches its catalyst PDUFA Feb 2017
$LXRX $15.32 Adding here. The action has been very weak, but it should start to move soon. Now holding a 3/4 position. Hopefully it will improve as it approaches its catalyst PDUFA Feb 2017
$XXII $0.94 Buying more here on the pullback. This continues to be a good trader in the past. This looks like an excellent entry
FDA reply on their application to market their VLN. "very low nicotine" cigarettes as "modified risk". This would be the first and only company able to market cigarettes as modified risk. Would be huge and lead to significant partnerships with big boys
$AAAP $27.99 Adding here on this show of relative strength. Now holding a 2X position, hoping for a rally as it approaches it's catalyst. PDUFA Dec 28
$XXII $1.12 Buying here on the pullback. This continues to be a good trader in the past and seems to be continuing to head up.
FDA reply on their application to market their VLN. "very low nicotine" cigarettes as "modified risk". This would be the first and only company able to market cigarettes as modified risk. Would be huge and lead to significant partnerships with big boys
$VCEL $2.42 Buying here on strength. Happy to see the trading improving. Hopefully it will continue as it approaches its catalyst PDUFA Jan 3 2017
$VCEL $2.20 Sold all but a toehold in this position. The action has been very weak here, so I'm going to put the cash on the side and watch things for a bit and see if it's trading improves before putting more into it. Hopefully it will improve as it approaches its catalyst PDUFA Jan 3 2017
I have lots of cash on the side and am actively looking for new trades.
$LXRX $16.59 Bought a bit more here as the action seems to be improving a bit. I'm watching this one closely. Now that the election is over... hopefully this will continue as it approaches its catalyst PDUFA Feb 2017
$DVAX $4.34 CRL - unfortunately I didn't exit before this pre market announcement. I decided to do a bit of a risky move on the back of what seemed to be a market over-reaction. I doubled down and bought more shares at the market open ($3.30)and sold again using a trailing stop as it regained come ground in early trading. A eager attempt to recover some of my losses before exiting this play.
When the smoke cleared, I locked in a loss of -45% (-$7939.44). It hurt for sure, but these things happen when you trade in biotech and I'm happy with my reaction to the news despite locking in a loss.
Moving on...
hope you sold before this morning
$LXRX $15.98 Sold all but a toehold in this position. The action has been very weak, so I'm going to put the cash on the side and watch things for a bit and see if it's trading action improves before putting more into it. Hopefully it will improve as it approaches its catalyst PDUFA Feb 2017
iBOX Updated with all current positions
Posted some significant losses in the last few weeks due to market volatility associate with the election.
I'm still playing mostly PDUFA plays but have added a couple of tickers in order to take advantage of the market volatility (XBI, XXII, LABU).
Going forward I'm going to be focusing on exiting positions that are posting losses sooner...
$DVAX $11.70 Added to my position here. Now holding 3/4 position and plan to add one more tranche as it approached its catalyst. PDUFA Dec 15, 2016
$LABU $44.23 This name has been on a steady appreciation lately. It's a good trader, but moves quickly. I will be adding to my initial entry here as the opportunities present themselves
$XXII $1.29 Bought some more in this name here as it shows signs of strength. This continues to be a good trader. Now holding 1/2 of a position.
FDA reply on their application to market their VLN. "very low nicotine" cigarettes as "modified risk". This would be the first and only company able to market cigarettes as modified risk. Would be huge and lead to significant partnerships with big boys
$XBI $57.04 Bought another tranche here as the market seems to have found a bottom on the recent pullback. Now holding 1 1/4 position. Will right size at the first opportunity and continue to watch for additional trading opportunities
$VCEL $2.25 Added to my position here. This name is still reeling from its recent financing but seems to have found a bottom. Now holding 1 3/4 overweight position. I will right size a soon as the opportunity presents itself as it moves towards it's catalyst. Jan 3 PDUFA
$LXRX $14.77 Added to my position here, now holding 1 1/4 position. I think this one has found it's bottom and will continue to move as it approaches its catalyst PDUFA Feb 2017
$DVAX $9.75 Bought a toehold position (<1%) to watch this one as it approached its catalyst. PDUFA Dec 15, 2016
$ONTX $2.40 Exited my position here. Locked in a slight loss (-1%, $947.95), but freed up significant cash for other plays. The US presidential election is bound to increase market volatility over the coming days and may present buying opportunities.
$CEMP $18.23 Exited my position here locking in a significant loss (-20%, $12,066) prior to the catalyst. This one has just not been tradition well over the last couple of weeks and there is some talk of a PDUFA delay and CRL. Current Catalyst: Adcom Nov 4, with back to back December PDUFA's. Dec 27, 28
It's disappointing when this happens, but recognizing when it is time to exit is part of the job of successful trading. For now I think my $$ is better off on the sidelines, ready for another play.
$XXII $1.40 Sold all but a starter position in this name on the pop today. This continues to be a good trader in the past and seems to be continuing to head up.
FDA reply on their application to market their VLN. "very low nicotine" cigarettes as "modified risk". This would be the first and only company able to market cigarettes as modified risk. Would be huge and lead to significant partnerships with big boys
$ONTX $2.67 Added to my position here on the pullback. Currently holding an overweight (1 1/2) position.
$LXRX $18.36 Added to my position here, now holding 3/4 position. I think this one will continue to move as it approaches its catalyst PDUFA Feb 2017
$CEMP $22.10 Added to my position here. Currently holding an over-weighted position (1 1/2). Will right size as this name bounces heading towards its Catalyst: Adcom Nov 4, Back to back December PDUFA's. Dec 27, 28
$VCEL $2.55 Added to my position on this pull back due to financing. Now holding 3/4 position and will continue to add as opportunities present itself as it moves towards it's catalyst. Jan 3 PDUFA
$VCEL $3.00 Slowly adding to my position. Now holding 1/4 position and will continue to add as opportunities present itself as it moves towards it's catalyst. Jan 3 PDUFA
$EGLT $7.99 Exited here on the pop at the open prior to catalyst. Locked in 7% gains ($2,075.21)
$ONTX $2.95 sold half my position here to right size. Still holding an overweight position. Have $60k on the side.
$XBI $66.51 Doubled my position here on the pullback. Now holding 1/2 position. Will continue to watch for trading opportunities.
$CEMP $25.06 Doubled down here. Currently holding a slightly over weighted position (1 1/4). Will right size as this name bounces heading towards its Catalyst: Adcom Nov 4, Back to back December PDUFA's. Dec 27, 28
$LXRX $17.74 Added to my position here on the pullback. I think this one will continue to move as it approaches its catalyst PDUFA Feb 2017
$VCEL $2.93 Added to my toehold position. Now holding 1/8th position and will continue to add as opportunities present itself as it moves towards it's catalyst. Jan 3 PDUFA
$XXII $1.40 Bought 1/2 position in this name on the gut feeling that it is going over $2.00, based on the strength I'm seeing. Swing Trade. This has been a good trader in the past and seems to be continuing to head up.
FDA reply on their application to market their VLN. "very low nicotine" cigarettes as "modified risk". This would be the first and only company able to market cigarettes as modified risk. Would be huge and lead to significant partnerships with big boys
$LXRX $18.02 re-entered here on this pull back with a toehold in order to watch the price action more closely. I thin this one will continue to move as it approaches its catalyst PDUFA Feb 2017
$VCEL $3.01 Sold all but a toehold of my current position on this significant move here. Will add as opportunities present themselves as it moves towards it's catalyst. Jan 3 PDUFA
$ONTX $2.93 Backed up the truck on this pull back. Will right size my position on the bounce. Currently holding a 2X+ overweight position and will sell as it continues to move into positive territory.
$EGLT $7.90 Selling a tranche here. Now holding a 1/2 position.
$LXRX $18.63 Re-bought this name ahead of it's delayed catalyst in order to watch it more closely. Holding up well today. Catalyst: PDUFA Feb 28, 2017
$ONTX $3.25 Sold half of my holdings to right-size my position here. Currently holding a slightly overweight position and will continue to sell as it continues to move into positive territory.
iBOX Updated with all current positions
$DRRX $1.71 Finally green and will start to trim as it approaches it's catalyst. Planning to be out VERY soon either way. PDUFA Sept 25
$ONTX $3.00 added 50% position to my holding here in an effort to cost average down as this name seems like it is starting to move. Holding an overweight position and will look to right size once it goes green.
$DRRX $1.65 Starting to look like it's finally starting to run towards its catalyst
$SCYX Sold my small position here on the pop to lock in 7% gains. Still holding a toehold and will add given the opportunity
Buy Date | Sell Date | Ticker | Entry Cost PPS | Exit Sell PPS | Gain/Loss | Notes | % + or - |
03-16-16 | 04/14/16 | FLML | $11.13 | $11.63 | +$1,137 | PDUFA Apr 30, Exited due to pending catalyst; locked in gains | +4% |
04-15-16 | 04/18/16 | MEIP | 1.66 | $1.51 | -$275 | Ph2 Data June 2016, Exited on Capital raise rumors | -6% |
04-04-16 | 04-19-16 | PGNX | $4.65 | $5.23 | +$1,757 | PDUFA July 18, Exited on 3% trailing stop to lock in gains | +8% |
03-16-16 | 04-19-16 | VNDA | $7.97 | $8.85 | +$3,827 | PDUFA May 27, Exited on 3% trailing stop to lock in gains | +16% |
04-05-16 | 04-19-16 | ACAD | $28.66 | $33.77 | +$946.14 | PDUFA May 01, Exited prior to calalyst to lock in gains | +5% |
04-15-16 | 04/25/16 | MBVX | $0.79 | $0.70 | -$507.15 | LOTTO Play - Initial Entry, Agreement with Juno by June 30th | -6% |
04-08-16 | 04-25-16 | PETX | 6.83 | 8.35 | +$1,135.02 | ADUFA 05-21-16 and 06-0716 | +18% |
04-11-16 | 05-03-16 | TRVN | $7.78 | $8.01 | -$2.67 | Ph 2b Results Released. Sold on the News | 0% |
04-18-16 | 05-05-16 | ADMP | $8.22 | $8.80 | +$1,384.66 | PDUFA May 29, Sold to lock in gains and free up cash | +7% |
04-20-16 | 05-17-16 | PETX | $6.94 | $6.53 | +$1249.90 | ADUFA May 21, 2016, Exit prior to Catalyst | +10% |
05-02-16 | 05-18-16 | SRPT | $16.23 | $17.21 | -$144.69 | PDUFA May 27th, Exit prior to Catalyst | -6% |
03-30-16 | 05-20-16 | VNDA | $8.20 | $9.72 | +$121.13 | PDUFA May 27, Exit prior to Catalyst | +3% |
04-11-16 | 05-23-16 | TTNP | $6.09 | $6.77 | +$2.307.53 | PDUFA May 27, 2016 | +10% |
05-25-16 | 05-27-16 | DNAI | $6.26 | $5.78 | -$114.85 | ASCO Conference June 6, exited on negative price action | -10% |
04-04-16 | 06-02-16 | PETX | $6.48 | $7.07 | +$930.19 | ADUFA June 07, 2016, | +8% |
04-15-16 | 06-02-16 | ONTY | $1.25 | $1.18 | -$526.75 | Run into ASCO June 3-8, 2016 | -6% |
06-07-16 | 06-15-16 | CASC | $1.20 | $1.04 | -$901.50 | Investor Day June 14 - 1/4 Position, exited on catalyst | -15% |
05-25-16 | 06/27/16 | LCPN | $9.25 | $7.25 | +$223.29 | PDUFA June 28. exited on catalyst | +3% |
04-04-16 | 07-08-16 | PGNX | $5.21 | $5.50 | +$1,496.19 | PDUFA July 18, exited on catalyst | +5% |
07-05-16 | 07-20-16 | OCUL | $4.88 | $5.25 | +$472.88 | PDUFA July 24. | +2% |
04-14-16 | 07-20-16 | DRRX | $1.35 | $1.53 | +$2,500.80 | PDUFA Sept 25 | +8% |
07-22-16 | 07-27-16 | ADMA | $6.77 | $7,28 | +$48.39 | PDUFA on or before July 30 - Exit on Catalyst | +3% |
07-08-16 | 08-03-16 | PETX | $6.99 | $8.16 | +$13,157.72 | ADUFA August 28th | +49% |
07-27-16 | 08-03-16 | XBI | $61.53 | $61.53 | +$329.94 | Locked in gains as it is looking overbought | +2% |
08-03-16 | 08-03-16 | RIGL | $2.79 | $3.09 | +$346.25 | Ph 3 Data in August, locked in gains on pop | +4% |
04-19-16 | 08-11-16 | CERU | $3.07 | $2.87 | -$5,633.29 | Ph 2 top line data 3Q2016. Exit prior to catalyst | -5% |
05-09-16 | 08-12-16 | PTLA | $27.34 | $27.26 | +$264.82 | PDUFA Aug 17,2016 | +0% |
08-12-16 | 08-15-16 | PETX | $9.55 | $9.80 | +$25.83 | ADUFA August 28th | +2% |
08-08-16 | 08-18-16 | RIGL | $2.96 | $2.86 | +$117.63 | PH III Data August 2016 | +2% |
08-23-16 | 09-06-16 | XXII | $1.07 | $1.10 | +$166.00 | Swing Trade, | +3% |
07-08-16 | 09-08-16 | ARLZ | $5.49 | $6.00 | +$5,598.36 | PDUFA Sept 14th, | +5% |
08-12-16 | 09-15-16 | LXRX | $15.83 | $18.71 | +$974.21 | PDUFA Oct 30, DELAYED | +7% |
08-12-16 | 09-19-16 | DCTH | $4.03 | $4.15 | +$229.72 | Presenting At CIRSE 2016 (Sep 10-14, 2016) | +1% |
04-14-16 | 09-22-16 | DRRX | $1.86 | $1.73 | -$958.15 | PDUFA Sept 25. | -2% |
08-23-16 | 11-10-16 | EGLT | $9.09 | $7.99 | +$2,075.21 | PDUFA Oct 14 - exited on catalyst | +7% |
09-09-16 | 11-01-16 | CEMP | $22.50 | $18.36 | -$12,066.45 | AdCom Nov 4 - exited on catalyst | -20% |
08-18-16 | 11-02-16 | ONTX | $3.93 | $2.40 | -$947.95 | Swing Trade - Weak action | -1% |
Buy Date | Sell Date | Ticker | Avg Cost PPS | Exit Sell PPS | Gain/Loss | Notes | % + or - | |
11-02-16 | DVAX | $11.30 | PDUFA Dec 15. Currently holding a 3/4 Position | |||||
11-09-16 | LABU | $43.26 | Trading on market swings, currently holding a 1/8 Position | |||||
09-26-16 | LXRX | $16.99 | PDUFA Feb 28. Currently holding a Full Position | |||||
09-13-16 | VCEL | $2.45 | PDUFA Jan 3. Currently holding a 2X Position | |||||
08-08-16 | XBI | $61.88 | Trading on market swings, currently holding a 1/8 Position | |||||
10-10-16 | XXII | $1.24 | Trading on market swings, currently holding a 1/8 Position |
Buy Date | Sell Date | Ticker | Entry Cost PPS | Exit Sell PPS | Gain/Loss | Notes | % + or - |
04-12-16 | 04-13-16 | ACAD | $31.07 | $33.11 | +$283 | Closed Position; locked in gains | +6% |
04-12-16 | 04-13-29 | BLUE | $47.58 | $50.06 | +230 | Closed Position; locked in gains | +5% |
04-13-16 | 4-18-16 | HRTX | $19.58 | $21.00 | +270.00 | FDA Decision Expected Early April 2016 | +7% |
04-12-16 | 4-18-16 | TTNP | $5.77 | $5.97 | +382.73 | PDUFA 05-27-16 | +7% |
04-12-16 | 04-28-16 | CYTR | $2.95 | $3.40 | +953.52 | Ph3 Data 06/16/16 | +8% |
04-21-16 | 05-03-16 | DRRX | $1.35 | $1.45 | +375 | APS Conf May 11th | +2% |
04-28-16 | 05-03-16 | TRVN | $7.81 | $7.97 | +501 | Ph 2b Results May 21 | +2% |
01-01-16 | 05-16-16 | MACK | $10.54 | $7.25 | -$18,000 | CHMP Opinion June 2016 | -50% |
04-25-16 | 05-18-16 | TTNP | $6.24 | $5.98 | -$810 | PDUFA 05-27-16 | -4% |
04-28-16 | 05-23-16 | IMMU | $3.69 | $4.10 | +3,545 | ASCO June 3-8. 2016 | +11% |
05-19-16 | 05-31-16 | CNAI | $5.88 | $6.28 | +1,924 | +7% | |
04-21-16 | 06-02-16 | PETX | $6.29 | $7.33 | +6,841 | ADUFA 05-21-16 and 06-0716 | +17% |
06-01-16 | 06-08-16 | ADMP | $5.91 | $3.76 | -$5.859 | PDUFA June 06, Recieved CRL | -36% |
06-01-16 | 06-09-16 | SCYX | $4.11 | $3.65 | -$2,625 | Phase 2 data July 2016 | -11% |
05-24-16 | 06-29-16 | LPCN | $8.90 | $3.15 | -$17,345 | PDUFA June 28. Held thru catalyst | -65% |
05-18-16 | 07-08-16 | PGNX | $4.59 | $5.49 | +876 | PDUFA July 18 | +19% |
Buy Date | Sell Date | Ticker | Avg Cost PPS | Avg Sell PPS | Gain/Loss | Notes | % + or - | |
06-07-16 | CASC | $1.14 | Investor Day June 14 - 1/4, Currently holding a Solid Position. | |||||
04-12-16 | CERU | $3.62 | Ph1b data 1H16. Ph 2 top line data 2Q16, Currently holding a Full Position. | |||||
06-07-16 | DRRX | $1.40 | PDUFA Sept 25, Currently holding a Full Position | |||||
07-05-16 | OCUL | $4.88 | PDUFA July 24. Sold 650 Shares @ $5.95, Currently holding a Solid Position | |||||
05-18-16 | PGNX | $4.59 | PDUFA July 18, Currently holding a Full Position | |||||
05-11-16 | PTLA | $23.05 | PDUFA Aug 17,2016, Currently holding a Full Position | |||||
01-01-16 | XBI | $71.58 | Currently holding a Overweighted Position | |||||
06-13-16 | ZYNE | $8.25 | Investor Conf Presentation July 13, Currently holding a Starter Position |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |